Search clinical trials for: Tenofovir DF placebo

Total 54756 results

Eastern Virginia Medical School
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Project ADHERE: Clinical Proof-of-Concept of a Tenofovir (TFV) Aptamer-Based Biosensor

HIV/AIDS | Adherence, Medication | Drug Use

United States
Rutgers, The State University of New Jersey

Active, not recruiting

IN-US-276-1340: Pre-Exposure Prophylaxis to Prevent HIV Acquisition in US Women: A Demonstration Project

PrEP Adherence Monitoring

United States
Kirby Institute
Government of Western Australia, Department of Health; Western Australia AIDS...

Completed

Western Australian Pre-exposure Prophylaxis for HIV Implementation Trial (PrEPIT-WA)

HIV Prevention

Australia
IlDong Pharmaceutical Co Ltd

Unknown

Switching From Tenofovir Disoproxil Fumarate to Besifovir Dipivoxil Maleate

Hepatitis B | Besifovir Dipivoxil Maleate | Tenofovir Disoproxil Fumarate

Korea, Republic of
Oswaldo Cruz Foundation

Unknown

Implementation of PrEP to HIV in Brazilian Transgender Women (PrEParadas)

HIV, Prevention

Brazil
Jan Gerstoft

Completed

Tenofovir Abacavir Platelet Activation Study (TAPAS)

HIV

Denmark
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID); Adult AIDS Clinical...

Terminated

Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV

HIV Infections

United States, Peru
University of North Carolina, Chapel Hill

Completed

A Key Link for Transmission Prevention (MP3)

HIV

Malawi
Asan Medical Center
Bristol-Myers Squibb

Unknown

Two Clinical Trials to Evaluate Pharmacokinetics of Unboosted and Boosted Atazanavir Used Alone or Co-administered With Tenofovir DF in Healthy Korean and Caucasian Male Volunteers

Atazanavir

Korea, Republic of
New Discovery LLC

Unknown

Maternal Therapy With TAF Versus TDF to Prevent Vertical Transmission of Hepatitis B

Hepatitis B, Chronic | Pregnancy Related

China
Mahidol University

Completed

Switching TDF/FTC/EFV to TDF/FTC/RPV VS Continuing TDF/FTC/EFV in HIV Patients With Complete Virological Suppression (STEREOS)

Dyslipidemias | HIV-1-infection | Sustained Virologic Response | Anti-Retroviral Agents | Efavirenz | Rilpivirine
St Stephens Aids Trust

Completed

PK of Tenofovir, Emtricitabine and Efavirenz in Healthy Volunteers

HIV Infections | HIV Infection

United Kingdom
Institut de Recherche pour le Developpement
Chiang Mai University; Ministry of Health, Thailand; Ministry of Health, Lao PDR

Active, not recruiting

Antiviral Prophylaxis and Infant Vaccination to Prevent Perinatal Hepatitis B Infection

Hepatitis B | Pregnancy

Thailand, Lao People's Democratic Republic
Instituto de Investigación Sanitaria de la Fundación...

Completed

The Benefits of Immediate Treatment Initiation Without Immunovirological Data Compared to Conventional BIC / FTC / TAF Treatment in Naive Patients With Type 1 HIV (Human Immunodeficiency Virus) Infection

HIV-1-infection

Spain
University of California, San Francisco
San Francisco AIDS Foundation; California HIV/AIDS Research Program

Completed

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy (I-BrEATHe)

HIV Prevention | Transgender Health

United States
Public Health Foundation Enterprises, Inc.
National Institute of Mental Health (NIMH); Emory University; San Francisco Department... and other collaborators

Completed

DOT Diary Mobile App for Pre-Exposure Prophylaxis Adherence in Young Men

Risk Behavior | HIV Prevention | Adherence, Medication | Pre-Exposure Prophylaxis

United States
ViiV Healthcare

Completed

New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects

HIV Infection | Infection, Human Immunodeficiency Virus I

United States, Spain, Germany, Canada, Belgium, Portugal, Italy, France, United Kingdom
Hoffmann-La Roche

Completed

A Study of Early Immunologic Response in Asian Patients With Chronic Hepatitis B, Treated With Pegasys (Peginterferon Alfa-2a (40KD)), Nucleoside Analogues, or Both

Hepatitis B, Chronic

Taiwan, United States, New Zealand, Singapore
Yonsei University

Unknown

Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination Therapy

Chronic Hepatitis B

Korea, Republic of
CONRAD
Gilead Sciences; International Partnership for Microbicides, Inc.

Completed

Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel

HIV Infections

United States, Dominican Republic
Vyne Therapeutics Inc.

Completed

Dermal Phototoxicity Study

Healthy
Assembly Biosciences

Completed

A Study in Healthy Volunteers and Patients With Chronic Hepatitis B

Chronic Hepatitis B

New Zealand
HepNet Study House, German Liverfoundation
Gilead Sciences; Hannover Medical School; Hoffmann-La Roche

Completed

HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis (HIDIT-II)

Hepatitis D

Germany, Greece, Romania
F-star Therapeutics, Inc.

Completed

A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV (ACHIEVE)

Hepatitis B | Hepatitis, Viral

Canada, Hong Kong, Korea, Republic of, Taiwan
Janssen Research & Development, LLC

Active, not recruiting

A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus Infection (OSPREY)

Hepatitis B, Chronic

France, Belgium, Italy, United Kingdom, Poland, Spain, New Zealand, Taiwan
Taipei Veterans General Hospital, Taiwan
China Medical University Hospital; Kaohsiung Medical University Chung-Ho Memorial... and other collaborators

Unknown

Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients

Chronic Hepatitis B

Taiwan
French National Agency for Research on AIDS and...
Gilead Sciences; Hoffmann-La Roche

Completed

Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)

HIV Infections | Leukoencephalopathy, Progressive Multifocal

France
Africa Health Research Institute

Recruiting

Long-Acting HIV Pre-Exposure Prophylaxis Integrated With Sexual and Reproductive Health - cRCT (LAPIS)

HIV Infections

South Africa
Ruijin Hospital

Recruiting

Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B Patients

Chronic Hepatitis

China
Hospital Clinic of Barcelona

Completed

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP) (RAL-PEP)

HIV Infection

Spain
Juan A. Arnaiz

Completed

Metabolic Effects of Atazanavir/Ritonavir Versus Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine in naïve HIV-1 Infected Patients

HIV-1

Spain
University of Alabama at Birmingham
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Recruiting

Reducing Vertical Transmission of Hepatitis B in Africa (REVERT-B)

Hepatitis B Infection

United States
Johns Hopkins University
National Institute of Allergy and Infectious Diseases (NIAID); CONRAD

Completed

Evaluating Distribution of a Tenofovir Douche With Tap Water Douching and Simulated Receptive Anal Intercourse (DREAM-02)

HIV/AIDS | HIV Prevention

United States
Centers for Disease Control and Prevention
Botswana Ministry of Health

Completed

Open Label Extension (OLE) of the TDF2 Study, Botswana (TDF2-OLE)

HIV Infections
Myanmar Oxford Clinical Research Unit
Institute of Tropical Medicine, Belgium; Medical Action Myanmar

Completed

PrEP Among MSM and TG in Myanmar (PrEP)

HIV Infections

Myanmar
Public Health Foundation Enterprises, Inc.
National Institute of Mental Health (NIMH); Emory University; San Francisco Department... and other collaborators

Completed

DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence

Risk Behavior | HIV Prevention | Adherence, Medication | Pre-Exposure Prophylaxis

United States
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy of Doravirine, Tenofovir, Lamivudine (MK-1439A) in Participants Infected With Treatment-Naïve Human Immunodeficiency Virus (HIV) -1 With Transmitted Resistance (MK-1439A-030) (DRIVE BEYOND)

HIV-1 Infection
Public Health Foundation Enterprises, Inc.
University of California, San Francisco; California HIV/AIDS Research Program; San Francisco Department of Public Health and other collaborators

Completed

The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community

Transgender Persons | Pre-Exposure Prophylaxis

United States
Federal University of São Paulo
Gilead Sciences

Unknown

HIV Drug Resistance Among Individuals Failing Tenofovir/Lamivudine and Dolutegravir First Line Regimen in Brazil

HIV | Drug | Resistance
New Discovery LLC
Gilead Sciences

Completed

Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus

Viremia | Hepatitis B Infection | Chronic Infection

China
Third Affiliated Hospital, Sun Yat-Sen University

Completed

The Safety of Anti-viral Therapy in Preventing HBV MTCT in Pregnant Women After Discontinuation

Hepatitis B, Chronic
St Stephens Aids Trust
Gilead Sciences

Completed

SSAT058: Atripla to Eviplera Switch in Patients Without Central Nervous System Symptoms

HIV

United Kingdom
Andrew Carr

Completed

Safety, Tolerability,and Adherence to Co-formulated Tenofovir-emtricitabine-rilpivirine Used as HIV Nonoccupational Post-exposure Prophylaxis in Men Who Have Sex With Men. (EPEP)

HIV Nonoccupational Post-exposure Prophylaxis in Men Who Have Sex With Men

Australia
GlaxoSmithKline

Completed

GSK1349572 Drug Interaction With Tenofovir

Healthy Subjects

United States
Taichung Veterans General Hospital
Gilead Sciences; Taipei Institute of Pathology

Terminated

Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma

Hepatocellular Carcinoma | Chronic Hepatitis B

Taiwan
Gilead Sciences

Completed

Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women (WAVES)

HIV Infections | Acquired Immunodeficiency Syndrome

United States, Thailand, France, Uganda, United Kingdom, Belgium, Portugal, Mexico, Dominican Republic, Italy, Puerto Rico, Russian Federation
ViiV Healthcare

Not yet recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy (VOGUE)

HIV Infections | HIV

Spain, Poland, France, Israel, Belgium, Portugal, Germany, Italy, Argentina, Greece, Japan, Ireland, Switzerland, United Kingdom, Denmark, Sweden, Mexico
University of California, Los Angeles
University of Cape Town

Completed

Postpartum Pre-exposure Prophylaxis (PrEP) Study to Evaluate an Adherence Promotion Package for Postpartum Women on PrEP (PPS)

HIV-1-infection

South Africa
Hospitales Universitarios Virgen del Rocío
Instituto de Biomedicina de Sevilla

Enrolling by invitation

Seville Cohort of People at Substantial Risk for HIV Infection on Pre-exposure Prophylaxis (SeVIHPrEP)

Hepatitis, Viral, Human | HIV Infection Primary | Sexually Transmitted Infections, Excluding HIV and Hepatitis

Spain
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir

HIV-1 Infection

United States

Search clinical trials for: Tenofovir DF placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations